The Most Expensive Drugs in the U.S. According to GoodRx
Sydney Otomancek2020-08-17T11:12:53-04:00August 17th, 2020|Categories: Featured, Industry News|Tags: Actimmune, AegerionPharma, EMDSerono, GoodRx HEOR, Horizon_Pharma, Mavenclad, Myalept, Oxervate, pharma, Ravicti|
GoodRx has released its latest list of the most expensive drugs in America, with orphan drugs and therapies for rare [...]
Amyrt’s Myalept Tops Ranking of Pharmacy Drugs by Price
Sydney Otomancek2023-12-14T13:20:06-05:00February 17th, 2020|Categories: Featured, Industry News|Tags: Amyrt Pharma, market access, Myalept|
Amyrt Pharma's Myalept is the most expensive pharmacy drug at $71,306 per month, according to a GoodRx report which ranks [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Beyond Accelerated Approvals: External Control Arms
Wednesday, April 10, 2024
Sponsor: Cardinal Health
Delphi Panels: What Are They Good For?
Tuesday, March 12, 2024
Sponsor: Partnership for Health Analytic Research (PHAR)
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
Thursday, February 29, 2024
Sponsor: Carelon Research
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
HEOR
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication